European Journal of Internal Medicine
Volume 19, Issue 2 , Pages 104-108 , March 2008

The value of C-reactive protein as a marker of systemic inflammation in stable chronic obstructive pulmonary disease

  • Fisun Karadag

      Affiliations

    • Department of Chest Diseases, School of Medicine, Adnan Menderes University, Aydin, Turkey
    • Corresponding Author InformationCorresponding author. Adnan Menderes University, Faculty of Medicine, Department of Chest Diseases, 09010 Aydin, Turkey. Tel.: +90 256 2120020/150; fax: +90 256 2146495.
    • ,
  • Sevin Kirdar

      Affiliations

    • Department of Microbiology, School of Medicine, Adnan Menderes University, Aydin, Turkey
    • ,
  • Aslihan B. Karul

      Affiliations

    • Department of Biochemistry, School of Medicine, Adnan Menderes University, Aydin, Turkey
    • ,
  • Emel Ceylan

      Affiliations

    • Department of Chest Diseases, School of Medicine, Adnan Menderes University, Aydin, Turkey

Received 18 December 2006 ,Revised 23 March 2007 ,Accepted 23 April 2007.

References 

  1. National Heart, Lung, and Blood Institute. Morbidity & mortality: chartbook on cardiovascular, lung, and blood diseases. Bethesda, MD: US Department of Health and Human Services, Public Health Service, National Institutes of Health; 1998. Available from: URL: www.nhlbi.nih.gov/nhlbi/seiin/other/cht-book/htm
  2. Murray CJL, Lopez AD. Evidence-based health policy-lessons from the Global Burden of Disease Study. Science. 1996;274:740–743
  3. Sin DD, Man SF. Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases? The potential role of systemic inflammation in chronic obstructive pulmonary disease. Circulation. 2003;107:1514–1519
  4. Anthonisen NR, Connett JE, Enright PL, Manfreda J. Lung Health Study Research Group. Hospitalizations and mortality in the Lung Health Study. Am J Respir Crit Care Med. 2002;166:333–339
  5. Schols AM, Buurman WA, Staal van den Brekel AJ, Dentener MA, Wouters EF. Evidence for a relation between metabolic derangements and increased levels of inflammatory mediators in a subgroup of patients with chronic obstructive pulmonary disease. Thorax. 1996;51:819–824
  6. De Godoy I, Donahoe M, Calhoun WJ, Mancino J, Rogers RM. Elevated TNF-α production by peripheral blood monocytes of weight-losing COPD patients. Am J Respir Crit Care Med. 1996;153:633–637
  7. De Torres JP, Cordoba-Lanus E, Lopez-Aguilar C, et al. C-reactive protein levels and clinically important predictive outcomes in stable COPD patients. Eur Respir J. 2006;27:902–907
  8. Gan WQ, Man SF, Senthilselvan A, Sin DD. Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis. Thorax. 2004;59:574–580
  9. Schneider A, Dinant GJ, Maag I, Gantner L, Meyer JF, Szecsenyi J. The added value of C-reactive protein to clinical signs and symptoms in patients with obstructive airway disease: results of a diagnostic study in primary care. BMC Fam Pract. 2006;7:28
  10. Pepys MB. C-reactive protein fifty years on. Lancet. 1981;1:653–657
  11. Pasceri V, Willerson JT, Yeh ET. Direct proinflammatory effect of C-reactive protein on human endothelial cells. Circulation. 2000;102:2165–2168
  12. Tracey KJ, Cerami A. Tumor necrosis factor: a pleiotropic cytokine and therapeutic target. Annu Rev Med. 1994;45:491–503
  13. Vernooy JH, Kucukaycan M, Jacobs JA, Chavannes NH, Buurman WA, Dentener MA, et al. Local and systemic inflammation in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2002;166:1218–1224
  14. NHLBI/WHO Global initiative for chronic obstructive lung disease (GOLD). Global strategy for the diagnosis, management and prevention of chronic obstructive lung disease (Updated 2006). Available from URL: http://www.goldcopd.com/
  15. ATS/ERS Task Force . Standardization of lung function testing. Eur Respir J. 2005;26:319–338
  16. Otsuji S, Shibata H, Umeda M. Turbidimetric immunassay of serum C-reactive protein. Clin Chem. 1982;28:2121–2124
  17. Aukrust P, Müller F, Lien E, Nordoy I, Liabakk N, Kvale D, et al. Tumor necrosis factor (tnf) system levels in human immunodeficiency virus-infected patients during highly active antiretroviral therapy: persistent TNF activation is associated with virologic and immunologic treatment failure. J Infec Dis. 1999;179:74–82
  18. MacNee W. Oxidative stress and lung inflammation in airways disease. Eur J Pharmacol. 2001;429:195–207
  19. Wouters EF. Chronic obstructive pulmonary disease. 5: systemic effects of COPD. Thorax. 2002;57:1067–1070
  20. Langen RC, Korn SH, Wouters EF. ROS in the local and systemic pathogenesis of COPD. Free Radic Biol Med. 2003;35:226–235
  21. Mukae H, Hogg JC, English D, Vincent R, van Eeden SF. Phagocytosis of particulate air pollutants by human alveolar macrophages stimulates the bone marrow. Am J Physiol Lung Cell Mol Physiol. 2000;279:L924–L931
  22. Gan WQ, Man SF, Sin DD. The interactions between cigarette smoking and reduced lung function on systemic inflammation. Chest. 2005;127:558–564
  23. Man SF, Connett JE, Anthonisen NR, Wise RA, Tashkin DP, Sin DD. C-reactive protein and mortality in mild to moderate chronic obstructive pulmonary disease. Thorax. 2006;61:849–853
  24. Dev D, Wallace E, Sankaran R, Cunniffe J, Govan JR, Wathen CG, et al. Value of C-reactive protein measurements in exacerbations of chronic obstructive pulmonary disease. Respir Med. 1998;92:664–667
  25. Hurst JR, Donaldson GC, Perera WR, Wilkinson TM, Bilello JA, Hagan GW, et al. Use of plasma biomarkers at exacerbation of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2006;174:867–874
  26. Van Helvoort HA, Heijdra YF, Thijs HM, Vina J, Wanten GJ, Dekhuijzen PN. Exercise-induced systemic effects in muscle-wasted patients with COPD. Med Sci Sports Exerc. 2006;38:1543–1552
  27. Man SF, Sin DD. Effects of corticosteroids on systemic inflammation in chronic obstructive pulmonary disease. Proc Am Thorac Soc. 2005;2:78–82
  28. Sin DD, Lacy P, York E, Man SF. Effects of fluticasone on systemic markers of inflammation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2004;170:760–765
  29. Broekhuizen R, Wouters EF, Creutzberg EC, Schols AM. Raised CRP levels mark metabolic and functional impairment in advanced COPD. Thorax. 2006;61:17–22
  30. Eid AA, Jonescu AA, Nixon LS, Lewis-Jenkins V, Matthews SB, Griffiths TL, et al. Inflammatory response and body composition in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2001;164:1414–1418
  31. Takabatake N, Nakamura H, Abe S, Hino T, Saito H, Yuki H, et al. Circulating leptin in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1999;159:1215–1219
  32. Tracey KJ, Cerami A. Metabolic responses to cachectin/TNF. A brief review. Ann N Y Acad Sci. 1990;587:325–331
  33. Di Francia M, Barbier D, Mege JL, Orehek J. Tumor necrosis factor-alpha levels and weight loss in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1994;150:1453–1455
  34. Takabatake N, Nakamura H, Abe S, Inoue S, Hino T, et al. The relationship between chronic hypoxemia and activation of tumor necrosis factor-α system in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2000;161:1179–1184
  35. Cirillo DJ, Agrawal Y, Cassano PA. Lipids and pulmonary function in the Third National Health and Nutrition Examination Survey. Am J Epidemiol. 2002;155:842–848
  36. Dentener MA, Creutzberg EC, Schols AM, Mantovani A, van't Veer C, Burman WA, et al. Systemic anti-inflammatory mediators in COPD: increase in soluble interleukin 1receptor II during treatment of exacerbations. Thorax. 2001;56:721–726
  37. Keatings VM, Collins PD, Scott DM, Barnes PJ. Differences in interleukin-8 and tumor necrosis factor-alpha in induced sputum from patients with chronic obstructive pulmonary disease or asthma. Am J Respir Crit Care Med. 1996;153:530–534
  38. Pinto-Plata VM, Mullerova H, Toso JF, Feudjo-Tepie M, Soriano JB, Vessey RS, et al. C-reactive protein in patients with COPD, control smokers and non-smokers. Thorax. 2006;61:23–28

PII: S0953-6205(07)00354-8

doi: 10.1016/j.ejim.2007.04.026

European Journal of Internal Medicine
Volume 19, Issue 2 , Pages 104-108 , March 2008

Article Tools